TITLE

Clinical digest. Evidence supports wider use of tranexamic acid in traumatic bleeding

PUB. DATE
October 2012
SOURCE
Nursing Standard;10/10/2012, Vol. 27 Issue 6, p15
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article discusses research in the article "Effect of Tranexamic Acid on Mortality in Patients With Traumatic Bleeding: Prespecified Analysis of Data From Randomised Controlled Trial" by I. Roberts et al. which found that tranexamic acid is safe and effective in treating traumatic bleeding.
ACCESSION #
82549084

 

Related Articles

  • Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register-Based National Cohort Study. Abrahamsen, Bo; Eiken, Pia; Eastell, Richard // Journal of Bone & Mineral Research;Jun2009, Vol. 24 Issue 6, p1095 

    The article reports on the results of research which was conducted in an effort to determine whether the use of the bisphosphonate alendronate in the treatment of fracture could lead to the development of additional atypical femur fractures. Researchers found that a high number of patients that...

  • Retreatment With Teriparatide One Year After the First Teriparatide Course in Patients on Continued Long-Term Alendronate. Cosman, Felicia; Nieves, Jeri W.; Zion, Marsha; Barbuto, Nancy; Lindsay, Robert // Journal of Bone & Mineral Research;Jun2009, Vol. 24 Issue 6, p1110 

    The article reports on the results of research which was conducted to determine whether a second retreatment course with teriparatide could produce similar biochemical and bone miineral density changes that were seen seen during a previous treatment in people who had been treated previously with...

  • New device stops bleeding faster.  // FDA Consumer;Jan/Feb96, Vol. 30 Issue 1, p2 

    Reports that the Vasoseal Vascular Hemostasis Device has received approval from the United States Food and Drug Administration. How device stops bleeding in angioplasty procedures; When the device was approved; How the device is used.

  • A memorable patient. Till, Kenneth // BMJ: British Medical Journal (International Edition);9/9/95, Vol. 311 Issue 7006, p681 

    Presents the author's recollection of using gauze to stop the bleeding of a patient on whose unprotected head had fallen a brick from a great height. Patient condition; Bleeding of the patient on removing the depressed bone; Recollection of George Grey Turner's recommendation for controlling...

  • Thrombospondin-2 Influences the Proportion of Cartilage and Bone During Fracture Healing. Taylor, Douglas K.; Meganck, Jeffrey A.; Terkhorn, Shawn; Rajani, Rajiv; Naik, Amish; O'Keefe, Regis J.; Goldstein, Steven A.; Hankenson, Kurt D. // Journal of Bone & Mineral Research;Jun2009, Vol. 24 Issue 6, p1043 

    The article reports on the results of research which was conducted in an effort to determine the impact thromospondin2 had on the proportion of cartilage and bone in fracture healing in mice. Researchers found that the use of thrombospondin-2 could be used as an alternative strategy for...

  • Warfarin-based genotyping not cost effective for most patients.  // Hem/Onc Today;3/10/2009, Vol. 10 Issue 5, p32 

    The article discusses research on the degree to which pharmacogenetic-guided dosing of warfarin improved risk for major bleeding compared to standard induction treatment with warfarin, published in the 2009 issue of the "Annals of Internal Medicine."

  • Prevention of Upper Gastrointestinal Bleeding. Peterson, Walter L. // New England Journal of Medicine;2/10/94, Vol. 330 Issue 6, p428 

    Editorial. Comments on an article by Jensen and his colleagues in the February 10, 1994 issue of the `New England Journal of Medicine.' Evidence that long-term maintenance therapy with histamine H2-receptor antagonists significantly reduces the incidence of recurrent bleeding in patients who...

  • 155-15. RESTART WARFARIN IN PATIENT WITH GI BLEEDING?  // Cortlandt Forum;01/25/2001, Vol. 14 Issue 1, p92 

    Answers a question about restarting warfarin therapy in an elderly black man who had experienced episodes of acute lower gastrointestinal (GI) bleeding. Success of previous anticoagulation with Coumadin; Risk of stroke in atrial fibrillation; Common reasons for not giving Coumadin in patients...

  • Halting hysterectomies.  // Herizons;Summer95, Vol. 9 Issue 2, p13 

    Reports that physicians in London, Ontario, have developed a procedure called uterine thermal balloon therapy which can be used to stop uterine bleeding and avoid unnecessary hysterectomies to some women.

  • Estrogen: A Novel Therapeutic Adjunct for the Treatment of Trauma-Hemorrhage--Induced Immunological Alterations.  // Molecular Medicine;Nov/Dec2008, Vol. 14 Issue 11/12, p752 

    A correction to the article about the new therapeutic adjunct for the treatment of trauma-hemorrhage-induced immunological alterations that was published in the March-April 2008 issue is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics